What is Biomind Labs Inc.?
, a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine based formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson's disease. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 8.14M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.